Mucinous glycoprotein (MUC-1) vaccine

Details for Australian Patent Application No. 2005244675 (hide)

Owner Oncothyreon Inc.

Inventors Longenecker, B. Michael

Agent Davies Collison Cave

Pub. Number AU-B-2005244675

PCT Pub. Number WO2005/112546

Priority 60/576,804 04.06.04 US; 60/558,139 01.04.04 US

Filing date 1 April 2005

Wipo publication date 1 December 2005

Acceptance publication date 21 July 2011

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/112546 Priority application(s): WO2005/112546

6 August 2009 Assignment before Grant

  Biomira, Inc. The application has been assigned to Oncothyreon Inc.

21 July 2011 Application Accepted

  Published as AU-B-2005244675

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244677-Suture device

2005244673-Leptin promoter polymorphisms and uses thereof